DBV Technologies DBVT
NASDAQ DBVT
$9.62 +0.14 (+1.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

DBV Technologies (DBVT) Restructuring Costs (2020)

Updated

DBV Technologies' Restructuring Costs was $2.55 million in Q4 2020.

Analysis

DBV Technologies (DBVT) Restructuring Costs (2020) Analysis & Trends

For FY2020, Restructuring Costs at DBV Technologies came in at $23.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 DBV Technologies 836.72 Mn 168.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.55 Mn
Sep 30, 2020 -286,000.00
Jun 30, 2020 21.29 Mn
API Access

DBV Technologies Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=DBVT&period=max&api_key=YOUR_API_KEY